Search

Start typing to see results...

  • Home
  • >
  • Stock Market
  • >
  • Jubilant Pharmova Ltd

Jubilant Pharmova Ltd share price and stock overview

Jubilant Pharmova Ltd (NSE: JUBLPHARMA, BSE: 530019) operates in the Pharmaceuticals - Indian - Bulk Drugs sector. The stock has an ISIN of INE700A01033 and a face value of Rs 1. As of 14 October 2026, it trades at Rs (940.50) with a market capitalisation of Rs 15021.19 crore. Figures are live and subject to change.

Jubilant Pharmova Ltd

Pharmaceuticals - Indian - Bulk Drugs
NSE BSE
940.50 -2.00 (-0.21%) downArrowC
As on: 14-Oct-2026 , 10:11 AM
Market Cap(₹Cr) 15021.19
Book Value(₹Cr) 145.1556811
BSE Code : 530019 NSE Symbol : JUBLPHARMA EPS(TTM) : 1.98 ISIN Demat : INE700A01033 P/E(TTM) : 476.24 Face Value(₹) : 1 Div & Yield % : 0.53

Today Market

Stock Performance

Today Market

Today's High

73,195.26

Todday's Low

72,894.41

Open at

73,049.76

Previous Close

73,033.78

Volumes

0.00

Avg Price

-33.45

Historical Performance

News

12 Oct 26
Jubilant Pharmova seeks to raise Rs 800 crore via private placement of NCDs
Jubilant Pharmova Limited announced the board’s approval to raise up to Rs 800 crore through the issuance of up to 80,000 fully paid-up, rupee-denominated, secured/unsecured, listed, rated, redeemable non-convertible debentures (NCDs) with a face value of Rs 1,00,000 each, on a private placement basis, potentially in multiple tranches, subject to regulatory approvals.
07 Oct 26
Jubilant Pharmova plans to raise funds via NCDs, pending board and shareholder approval
Jubilant Pharmova Limited will hold a board meeting on Monday, October 12, 2026, to consider and approve raising funds through the issuance of Non-Convertible Debentures (NCDs) and/or other securities, and to seek shareholder approval as required.
05 Oct 26
Jubilant Pharmova confirms regulatory compliance with Alankit Assignments for the September quarter
Jubilant Pharmova Limited, in a filing with the BSE Limited and National Stock Exchange of India Limited on October 5, 2026, received a certificate from Alankit Assignments Limited, its Registrar and Share Transfer Agent, confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026.
29 Sep 26
Jubilant Pharmova halts trading for insiders following quarterly results announcement
Jubilant Pharmova Limited will close its trading window for designated persons and their immediate relatives starting Thursday, October 1, 2026, and continuing until 48 hours after the company announces its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026.

Historical Prices

Share Price Chart

Historical Share Price

From Date:
To Date:     
Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
13-10-26 956.20 956.30 921.40 942.50 457491 29609 428739325.70 22721.95
12-10-26 931.90 969.90 908.00 950.90 1419970 38800 1325856557.90 22363.35
09-10-26 940.40 950.00 917.60 931.90 123186 12425 114285911.10 22520.45
08-10-26 971.00 974.60 921.50 932.20 417017 20850 388943949.70 22231.80
07-10-26 991.20 993.80 971.00 974.60 69406 11826 67931500.30 22603.05
06-10-26 982.00 996.60 970.10 989.20 174777 17332 172259449.20 22776.10
05-10-26 999.80 1012.00 972.10 981.60 203076 22717 199930739.90 22555.75
01-10-26 1026.00 1028.60 980.30 999.30 336042 25393 334894586.50 22421.95
30-09-26 1052.10 1063.10 1021.60 1028.80 460073 29569 475692533.90 22620.45
29-09-26 1058.00 1089.65 1036.20 1048.20 1060299 54176 1118616532.40 22716.20
123...

Fundamentals

Company Valuation

Market Cap (₹cr)

15021.19

PE Ratio

476.24

PB Ratio

6.50

Dividend Yield

0.53

ROE

3.06

ROCE

1.79

Book Value (₹)

145.1556811

Face Value (₹)

1

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 5230455 3.28 5230455 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 5000 0.00 5000 1
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 5235455 3.29 5235455 2
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 68804742 43.20 68804742 5
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1898425 1.19 1898425 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 70703167 44.39 70703167 9
Total ShareHolding for Promoter & Group 75938622 47.68 75938622 11
plus   Publice Share Holding
plus  Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 2645 0.00 2045 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 25280499 15.87 25280499 146
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 1791940 1.13 1791940 2
Mutual Funds / UTI 14326627 8.99 14326627 23
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 3628501 2.28 3628501 14
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 45030212 28.27 45029612 187
plus  Non Institution
Bodies Corporate 4971542 3.12 4971542 695
Clearing Members 148914 0.09 148914 24
Directors & their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1933070 1.21 1912055 2527
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 581787 0.37 581787 1387
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 10244000 6.43 10244000 2
Individuals holding nominal share capital up to Rs. 1 lakh 17088028 10.73 16781008 77767
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 19032 0.01 19032 8
Others 1989722 1.25 1989722 1
Sub Total 37433704 23.50 37105669 82504
Total Public Shareholding 82463916 51.77 82135281 82691
Total of Promoter & Public ShareHolding 158402538 99.45 158073903 82702
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 878601 0.55 878601 1
Total Shares held by Custodians and against which Depository Receipts have been issued 878601 0.55 878601 1
Grand Total 159281139 100.00 158952504 82703

Financials (₹ in cr)

Consolidated Standalone
Year EndMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Net Sales8,279.607,234.506,702.906,281.706,130.16
OPM (%)8.138.595.061.3510.28
OP673.30621.10339.4084.60630.45
Other Income66.0056.8068.7038.3011.29
PBIDT1,266.301,589.50824.70770.001,157.64
INTEREST211.80240.30272.30188.20145.49
PBDT1,054.501,349.20552.40581.801,012.15
PBT554.901,340.101.60-29.00630.45
EO-59.20359.50-168.90-56.800.00
PBT after EO614.10980.60170.5027.80630.45
TAXES216.60144.3097.8092.70217.43
PAT398.50839.4077.10-61.00413.94
EPS25.0852.854.86-3.8326.00
Raw Material28.0227.4427.1726.5322.00
Power and Fuel1.882.132.222.652.19
Employee Cost32.6231.3533.0634.4833.33
Other Manufacturing Expenses0.000.000.000.000.00
Selling and Administration Expenses10.0210.1710.7910.4110.87
Miscellaneous Expenses0.690.791.001.151.46
Revenue (Growth %) 14.457.936.712.470.52
PBIDT (Growth %)-20.3392.747.10-33.49-17.55
PAT (Growth %) -52.53988.72-226.39-114.74-50.48
PBIDT (Margin %)15.2921.9712.3012.2618.88
PAT (Margin %) 4.8111.601.15-0.976.75

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Share Capital 15.9015.9015.9015.9015.9315.93
Reserves Total 2296.402302.202358.602398.602423.141266.52
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds2312.302318.102374.502414.502439.071282.45
Secured Loans 50.00213.40261.40222.5095.0095.00
Unsecured Loans 2.70122.80119.10123.1087.52408.71
Total Debt52.70336.20380.50345.60182.52503.71
Other Liabilities12.2028.0027.4023.4024.065.34
Total Liabilities2377.202682.302782.402783.502645.651791.50
APPLICATION OF FUNDS :
Gross Block 155.801035.70997.30947.40863.48148.93
Less : Accumulated Depreciation 39.90337.00286.00260.00226.9721.85
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 115.90698.70711.30687.40636.51127.08
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress11.5019.3037.0047.0035.260.33
Producing Properties0.000.000.000.000.000.00
Investments 2176.001657.001656.901656.601645.751645.98
Current Assets, Loans & Advances
Inventories 0.00232.40250.90313.60323.180.00
Sundry Debtors 23.80206.30194.20188.50130.700.00
Cash and Bank Balance10.3012.6036.1011.0022.5340.33
Loans and Advances 16.8032.9059.4065.7049.4025.92
Total Current Assets50.90484.20540.60578.80525.8166.25
Less : Current Liabilities and Provisions
Current Liabilities 37.50206.30202.40213.70238.8432.94
Provisions 18.0021.007.1011.2011.0711.30
Total Current Liabilities & Provisions55.50227.30209.50224.90249.9144.24
Net Current Assets-4.60256.90331.10353.90275.8922.00
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets228.90126.40126.40128.6036.690.00
Deferred Tax Liability183.40114.80114.50111.601.358.86
Net Deferred Tax45.5011.6011.9017.0035.34-8.86
Other Assets32.9038.8034.2021.6016.904.96
Total Assets2377.202682.302782.402783.502645.651791.49
Contingent Liabilities89.2066.1077.5070.3070.0768.85

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Financing Activities -107.3722.50-77.80-156.80-129.90
Investing Activities 93.1031.10-40.30-2.3034.00
Net Cash Flow -17.82-11.5025.10-23.50-2.30
Operating Activities -3.55-65.10143.20135.6093.60

Peers

Balance Sheet Financial Ratios Profit & Loss
Aarey Drugs & Ph...

102.61

(-0.34%)
Aarti Drugs Ltd

408.20

(-0.45%)
Acutaas Chemical...

3,123.70

(-1.67%)
Anuh Pharma Ltd

82.87

(+1.97%)
Asston Pharmaceu...

Astonea Labs Ltd

Auro Laboratorie...

Bacil Pharma Ltd

Corporate Actions

Bonus Dividends Splits
DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer
SSB
Shyam S Bhartia
Chairman & Non Executive Dir.
Executive
HSB
Hari S Bhartia
Co-Chairman / Non Executive Director / Promoter
Executive
Independent Directors
SKR
S K Roongta
Independent Non Exe. Director
Ind.
VM
Vivek Mehra
Independent Non Exe. Director
Ind.
AS
Arun Seth.
Independent Non Exe. Director
Ind.
SGB
Shirish Gundopant Belapure
Independent Non Exe. Director
Ind.
SN
Shivpriya Nanda
Independent Non Exe. Director
Ind.
HM
Harsh Mahajan
Independent Non Exe. Director
Ind.
Company Secretary & Compliance
NK
Naresh Kapoor
Company Secretary / Compliance Officer
Sec.
Other Officials
PB
Priyavrat Bhartia
ED / MD / Promoter
Board
ASB
Arjun Shanker Bhartia
ED / Joint MD / Promoter
Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Jubilant Pharmova Ltd? −

Jubilant Pharmova Ltd trades on NSE under JUBLPHARMA and on BSE under code 530019. The ISIN is INE700A01033 and the face value is Rs 1.

What is the share price of Jubilant Pharmova Ltd today? +

As of 14 October 2026, Jubilant Pharmova Ltd trades at Rs 940.50, a change of -2.00 (-0.21%) on the day. Prices are live and subject to change.

What is the market capitalisation of Jubilant Pharmova Ltd? +

As of 14 October 2026, Jubilant Pharmova Ltd has a market cap of about Rs 15021.19 crore. This figure is live and moves with the share price.

Is Jubilant Pharmova Ltd profitable? +

In March 2026, Jubilant Pharmova Ltd reported a profit after tax of Rs 398.50 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Jubilant Pharmova Ltd? +

: As of 14 October 2026, the PE (TTM) for Jubilant Pharmova Ltd is 476.24 and the price-to-book ratio is 6.50. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Jubilant Pharmova Ltd pay a dividend? +

As of 14 October 2026, the dividend yield for Jubilant Pharmova Ltd is 0.53%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Jubilant Pharmova Ltd? +

As of the latest disclosed pattern, promoters hold 47.68% of Jubilant Pharmova Ltd. Public shareholding is 51.77%, including mutual funds at 8.99% and foreign institutional investors at 15.87%.

What were the latest annual financials of Jubilant Pharmova Ltd? +

In March 2026, Jubilant Pharmova Ltd reported net sales of Rs 8,279.60 crore, revenue growth of 14.45%, and earnings per share of Rs 25.08.